July 17, 2017 | Rapid Medical, an Israeli company that develops neurovascular interventional devices, raised $9 million in a Series B financing round. Founded in 2008 by CEO Ronen Eckhouse and Chairman of the Board Shimon Eckhouse, Rapid Medical is seeking to further commercialize TIGERTRIEVER Revascularization Device and the COMANECI Adjustable Remodeling Mesh, products which provide prevention and minimally invasive stroke treatment. Israel’s BRM and China’s Shanghai-Israel Investment Fund led the round, while Winnovation and Gefen Capital participated. [Photo: Courtesy]
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments